Undergraduate

2,892 views
2,739 views

Published on

Published in: Education, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,892
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Undergraduate

  1. 1. CURRICULUM VITAE PROFESSOR ABDALLAH S. DAAR A. BIOGRAPHICAL INFORMATION 1. Address Professor of Public Health Sciences and of Surgery, University of Toronto and Director Ethics and Commercialization, McLaughlin-Rotman Centre for Global Health 101 College Street, South Tower, Suite 406 Toronto, Ontario, M5G 1L7, CANADA Tel: 416-673-6573 Fax: 416-352-1606 E-mail: a.daar@utoronto.ca Website: www.mrcglobal.org 2. Medical Schools Undergraduate • St. Thomas’ Hospital Medical School, University of London, London, England (1972-1973) • Makerere University, Kampala, Uganda (1968-1972) Postgraduate • Oxford University (1976-1983) 3. Degrees /Qualifications/Fellowships • FRS(C) (2006) • FRCS (C) (2001) • FRCP (Lond.). (1995) • D. Phil (Oxon). (1983) Nuffield Department of Surgery, Faculty of Medicine, Oxford University/Wolfson College (Immunology) • FRCSEd. (1978) Nuffield Department of Surgery, Oxford University/Royal College of Surgeons of Edinburgh • FRCS. (1977) Nuffield Deptartment of Surgery, Oxford University/Royal College of Surgeons • MRCP (UK). (1977) Nuffield Department of Surgery, Oxford University/Royal College of Physicians of London • LRCP (Lon.), MRCS (Eng.). (1973)
  2. 2. Curriculum Vitae, Daar AS St. Thomas' Hospital Medical School (University of London) (1972-3) & Makerere University, Uganda (1968-72) 4. Licensure • Principal List of the General Medical Council of Great Britain (Registration # 1599132) • Specialist Register (General Surgery) of the The Specialist Authority of the UK Medical Royal Colleges • Ontario College of Physicians and Surgeons College Register No. 78603 • Maintenance of Certification Program at The Royal College of Physicians and Surgeons of Canada (2002-2007) 5. Employment Current, Academic • Professor of Public Health Sciences, University of Toronto (2001-) • Professor of Surgery, University of Toronto (2001-) • Senior Scientist and Director of Ethics and Commercialization, McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto (2008-) • Senior Scientist and Director of Ethics and Policy, McLaughlin Centre for Molecular Medicine, University of Toronto (2004- ) • Senior Scientist, Research Institute, The Hospital for Sick Children (2002-) • Associate Scientist, Samuel Lunenfeld Research Institute, Mount Sinai Hospital (2002-) • Member, School of Graduate Studies, University of Toronto (2002-) • Member, Institute of Medical Sciences, University of Toronto (2002-) Previous, Academic • Co-Director, Canadian Program on Genomics and Global Health, University of Toronto Centre for Bioethics (2001-2007) • Director, University of Toronto Program in Applied Ethics and Biotechnology, University of Toronto Joint Centre for Bioethics (2001-2007) • Professor and Chairman, Department of Surgery, College of Medicine, Sultan Qaboos University, Oman (1988-98) • Professor, Department of Surgery, College of Medicine, Sultan Qaboos University, Oman (1988-2000) • Visiting Professor, Department of Surgery, University of Toronto (July 1998 - February 1999) • Visiting Professor in Health Policy and Society, Faculty of Law and Joint Centre for Bioethics, University of Toronto (July 1998 - March 1999) • Visiting Scholar, Center for Biomedical Ethics, Stanford University (February - June 1998) • Member, Steering and Foundation Committees/Transitional Council, Faculty of Medicine and Health Sciences, United Arab Emirates University (1985-88) • Founding Director, Emirates Institute for Medical Research, United Arab Emirates (1985-88) 2
  3. 3. Curriculum Vitae, Daar AS • Surgical Tutor, Clinical Lecturer, Medical Research Council of Great Britain Training Fellow, Lecturer in charge of lymphoma service, and Fellow in Transplantation, Nuffield Department of Surgery, University of Oxford (1979-84) • Visiting Professor, Department of Anatomy, University of Houston (1975) Previous, Clinical • Senior Consultant Surgeon, University Hospital, Sultan Qaboos University, Oman (1988-2000) • Chief of Surgery, University Hospital, Sultan Qaboos University, Oman (1988-98) • Head of Surgery, Oman Transplant Program (1988-2000) • Senior Consultant Surgeon, The Royal Hospital, Oman (1988-91) • Senior Consultant Surgeon and Head of Clinical Transplant Programme, Mafraq Hospital, United Arab Emirates (1984-87) • Senior Registrar (Clinical component of lecturer position), Nuffield Department of Surgery, John Radcliffe Hospital, Oxford (1979-84) Supervisors: Professor PJ Morris (General, Transplantation and Vascular Surgery), Mr. J. Collin (General and Vascular Surgery), Mr. RMF Wood, Professor Morris and Dr. AH Laing (Lymphoma Surgery), Mr. MJ Britton (Pancreatio- biliary Surgery), Mr. NE Dudley (Paediatric and Endocrine Surgery), Mr. JC Smith (Urology), and [Mr. Gunning (Thoracic)] • Registrar, (Middle Grade) in General Surgery/Urology, Gloucestershire Royal Hospital, Gloucester, UK (1978-79) Supervisors: Mr. MWL Gear, Mr. D Calvert, and Mr. H Thomson • SHO (Surgery), Nuffield Department of Surgery (Churchill Hospital and Radcliffe Infirmary), Oxford (1976-77) Supervisors: Professor PJ Morris, Mr. M Kettlewell, Mr. BJ Britton, and Mr. HW Steer • SHO Accident & Emergency and Demonstrator in Anatomy, St. Thomas' Hospital Medical School, London (1974-75) • House Officer (Intern) Medicine and Surgery, Queen Alexandra Hospital, Cosham, Portsmouth UK (1973-74) Committees at University of Toronto • Member of the Academic Promotions Committee, Faculty of Medicine, University of Toronto (-2009) • Chair, Education Committee – McLaughlin-Rotman Centre for Global Health Member, Decanal Promotions Committee, University of Toronto (2005-) • Member, Director Search Committee, University of Toronto Joint Centre for Bioethics (2005-) • Member , University of Toronto Tribunal (2004-06) • Member, Executive Committee of the Collaborative Program in Bioethics, University of Toronto (2002-) • Member, Committee for International Surgery, Office of International Surgery, University of Toronto (2002-) • Member, University of Toronto Joint Centre for Bioethics Management Committee (2002-) • Member, Molecular Medicine Executive Committee, University of Toronto (2001-) • Member, Advisory Committee, Centre for International Health, University of Toronto (2001-) • Member, Advisory Committee, Joint Centre for Bioethics, University of Toronto (2001-) 3
  4. 4. Curriculum Vitae, Daar AS Committees in Oman Previous (University and Hospital • Chairman, Five-Year Strategic Planning Committee (Raising Our Sights), Sultan Qaboos University, College of Medicine (1999-2001) • Member, Medical Research and Ethics Committee, Sultan Qaboos University (1999-2000) • Editor-in-Chief, Sultan Qaboos University Journal of Scientific Research (Medical Sciences) (~1997-2000) • Deputy Chairman, Oman National Renal Failure and Transplantation Committee (~1997-2000) • Member, Scientific Publications Committee, Sultan Qaboos University • Member, Oman Medical Specialties Board, Sultan Qaboos University (1996-98) • Member, Joint Health Committee, Sultan Qaboos University/ Ministry of Health (~1995-98) • Chairman, Medical Advisory Committee, Sultan Qaboos University Hospital (~1993-95; 1999-2000) • Member, Hospital Board, Sultan Qaboos University Hospital (~1993-95; 1999-2000) • Chairman, Clinical Curriculum Committee, Sultan Qaboos University (1990-98) 6. Honours and Prizes Honours: • Fellow of The Hastings Center (2009-) • Fellow of the Islamic Academy of Sciences (2009-) • Fellow of The Academy of Sciences for the Developing World (TWAS) (2007-) • Fellow of the Royal Society (Canada) (2006-) • Fellow, Canadian Academy of Health Sciences (2006-) • Fellow, New York Academy of Sciences (1998-) • Senior Fellow, Massey College, University of Toronto (2006-) • UNESCO Avicenna Prize for Ethics in Science, UNESCO (2005) • Inaugural Lecturer of The Bourns Lecture in Bioethics at McMaster University (2004) • Hunterian Professor, Royal College of Surgeons of England (1999) • Jan Brod Lecturer, University of Oxford (1999) • Ellen Picard Lecturer, Health Law Institute, Faculty of Law, University of Alberta (1999) • Panel of Examiners, Royal College of Surgeons of Edinburgh (1999-2003) • Distinguished Foundation Visitor, Royal Australasian College of Surgeons (Universties of Auckland, Otago, Sydney and Queensland) (1996) • President, First International Congress on Transplantation in Developing Countries, Singapore (May 1993) 4
  5. 5. Curriculum Vitae, Daar AS • Official world record for performing the youngest cadaveric-donor kidney transplant (records kept at UCLA) • Best Teacher of the Year Sultan Qaboos University College of Medicine 1989/1990 • Medical Research Council of Great Britain Award to Triennial Convocation of Nobel Prize winners in medicine/physiology, Lindau, Germany (1981) • Medical Research Council of Great Britain Training Fellowship (1980-83) • University Exhibition (Academic Achievement) Makerere University Medical School, Uganda (1969-70) • University Entrance Scholarship, Makerere University Medical School, Uganda (1968) Research Prizes • Patey Prize: Daar AS, Fabre JW. Demonstration with monoclonal antibodies of an unusual mononuclear cell infiltrate and of normal epithelial membrane antigens in human breast carcinoma. Summer Meeting, Surgical Research Society of Great Britain. Cardiff, Wales, July 1981. Awarded the Patey Prize of the Surgical Research Society of Great Britain for this work. Abstract published in British Journal of Surgery 1981; paper published in Lancet 1981; 8244: 434-8. • Hunterian Professor, Royal College of Surgeons of England (1999) • UNESCO Avicenna Prize for Ethics in Science, UNESCO (2005) • Anthony Miller Award for Research Excellence, University of Toronto (2005) • 2004 Award for Best Clinical Sciences Research Kuwait University 9th Annual Health Sciences Center Kehinde EA, Akanji AO, Daar AS, Luqmani Y, Bashir AA, Al Awadi KA. Do differences in age-specific serum adrenal C19 steroid hormone levels account for differing prostate cancer rates between Arabs and Caucasians. 8. Professional Affiliations and International Activities • Nominations committee, Royal Society Canada (2009) • Member of the Scientific Board for the National Heart, Lung and Blood Institute, Global Health Initiative (USA) (2009) • Chair of the Board, Global Alliance for Chronic Diseases (2009-) • Chair, Board of Advisors, United Nations University International Institute for Global Health (2009-) • Member of the Board, MEND (Medicine in Need), (2008-) • Chair of the Steering Committee of MEND Innovation and Translation Alliance Management (MITAM) (2009-) • Member, International Bioethics Committee, UNESCO (2008-) 5
  6. 6. Curriculum Vitae, Daar AS • Member of the Advisory Board of the United Nations University’s International Institute for Global Health (UNU-IIGH) in Kuala Lumpur (September 2008) • Visiting Professor, Faculty of Medicine, University of Kuwait (April 2008) • Trustee and Member of Executive Committee, SciDev.Net Board (2008-) • Member, International Scientific Council and Executive Committee, Israeli Palestinian Science Organization (IPSO) [2007-] • Advisor to the United Nations Secretary General’s Office on Biotechnology and Human Security (2007-) • Adjunct Member, University Ethics Review Committee, The Aga Khan University (2007-2009) • Member, African Union High Level Panel on Modern Biotechnology (2005-) • Member, Executive Committee, The International Human Rights Network of Academies and Scholarly Societies (based at the US NAS) (2005-) • Member , Senior Advisory Panel, International Life Sciences Council (2006-) • Member, Peer Review Committee for Chair in Neuroethics, CIHR Institute of Neurosciences, Mental Health and Addiction (2006) • Member – Steering Group of GRaPH-Int (Genome-Based and Population Health International Network (2006) • Member, Research Policy Advisory Committee, Canadian Institutes of Health Research (2006-) • Member, Research Management Committee of Stem Cell Network (2006-7) • Executive Council Member, PharmacoGenetics for Every Nation Initiative, Washington University, St. Louis, USA (2006-) • Faculty Associate, Centre for Ethics, University of Toronto (2006-) • Consultant, WHO Roll Back Malaria Program, Geneva (Consultation on WHO Roles and Functions in Achieving RBM Goals and Targets). (Nov. 2005) • Member, Scientific Advisory Board, The Centre for Applied Genomics Research Institute, The Hospital for Sick Children, Toronto (2005-) • Member, Taskforce on Nanotechnology and Ethics, Division of Ethics of Science and Technology of UNESCO with the World Commission on the Ethics of Scientific Knowledge and Technology (COMTEST) (2005-) • Full member/Principal Investigator, Stem Cell Network, Canada (2005-2007) • Chair, 4th Independent External Review of UNDP/ UNICEF/ World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) (2004-) • Rockefeller Foundation Joint Learning Initiative on "Enhancing Problem-Solving Capacity for Priority Diseases of the Poor." On two working groups (Africa, and Innovation) of “Strategies on Human Resources for Health and Development” (2004-) • Canadian Biotechnology Advisory Committee Expert Working Party on Human Genetic Materials, Intellectual Property and the Health Sector (2004-2006) • College of Reviewers, Canada Research Chairs (2004-) 6
  7. 7. Curriculum Vitae, Daar AS • Member, Expert Advisory Committee on Cells, Tissues and Organs (EAC-CTO), Health Canada (2004-2006) • Member, Canadian Coalition for Global Health Research (CCGHR) (2004-) • Member, Steering Committee, McLaughlin-Rotman Centre for Global Health • Member, McGill Centre for Intellectual Property Policy • Member, Ontario Genomics Institute Ethics GE3LS Committee • Member, Panel of Experts, Human Genetics Programme (HGN), World Health Organization (WHO) (2003-) • Member, Program Advisory Committee, Canadian Institutes of Health Research Program on Regenerative Medicine (2002) • Member, Ethics and Equity Committee, the Royal College of Physicians and Surgeons of Canada (2002-2006) • Member and Ethics Lead, Institute Advisory Board, Institute for Infection and Immunity, Canadian Institutes for Health Research (2001-04) • Member, Advisory Committee, Centre for International Health, University of Toronto (2001-) • Board of Consultants, German Academy of Transplantation Medicine (2000-) • Member, Ethical, Legal, and Social Issues Committee, Human Genome Organization (1999-) • Core Group, Meech Lake International Initiative on Science and Ethics (1999-2000) • Member, Advisory Committee, 5th International Congress on Xenotransplantation, Japan (1999) • Rapporteur, Working Party on Genetic Recombinations, World Health Organization (1998-99); and Author of WHO’s Daar-Mattei Report (At request of Director-General of WHO) • Steering Committee, Executive Course, "Understanding the New World of Health Care -An Intensive Program for Canadian Leaders." Run jointly by the University of Toronto Joseph L. Rotman School of Management and Harvard University (1998) • Member, Ethics Committee, Asian Transplantation Society (1998-2005) • Chairman, WHO Consultation on Xenotransplantation (1997) See report at http://www.who.int/emc-documents/zoonoses/docs/whoemczoo982.pdf • Member, Taskforce on Organ Transplantation, World Health Organization (1995-96) • Member, Bellagio Taskforce on Transplantation, Bodily Integrity and the International Traffic in Organs (~1994-96) • Member (Hon.), Munich Working Group on the Living Donor (1996) • External Examiner in Surgery, Faculty of Medicine and Health Sciences, Arabian Gulf University (Past) • Member, Ethics Committee, The ( International) Transplantation Society (~1992-2003) • Councillor, Asian Society of Transplantation (~1992-) • Councillor, Middle East Society for Organ Transplantation (past) • Faculty, Einstein Institute for Science, Health and the Courts (EINSHAC) (~1999-2002) • Faculty, National Judicial Institute, Canada (2002) 7
  8. 8. Curriculum Vitae, Daar AS Professional Societies • Member, The (International) Transplantation Society • Honorary Life Member, South African Transplantation Society • Member, Transplantation Society of Australia and New Zealand • Member, British Society of Immunology (past) • Member, British Transplantation Society (past) • Member, Society for Organ Sharing (past) Memberships in the Editorial Boards • Member, Editorial Board of BMC Medical Genomics (2007-) • Editorial Board, Islamic Educational, Scientific and Cultural Organization and Malaysia Biotechnology Information Centre (ISESCO-MABIC) (April 2008) • Editorial Board, International Journal of Technology and Globalization (2005-) • Editorial Board, Journal of Genomics, Society and Policy (2005-) • Editorial Board, Journal of Genomic Medicine (2005-) • Editorial Board, Journal of Globalization and Health (2004) • Special Issue Editor on Policy and Ethical Issues in Surgery, World Journal of Surgery (2001) • Member, Advisory Board, Journal of Kuwait Medical Association • Member, International Scientific Advisory Board, Transplant Asia (2004-) • Member, Editorial Board, Journal of Experimental and Clinical Transplantation (2003-) • Member, Advisory Board, Bioethics (2000-04) • Member, Editorial Board, World Journal of Surgery (1998-2001) • Member, Advisory Board, Kidney Forum (~1997) • Member, Advisory Board, Brazilian Transplant Journal (~1997-) • Member, Advisory Board, Transplantation India (~1997) • Member, Advisory Board, Transplantation in Developing Nations (1997) • Consulting Editor, Emirates Medical Journal (~1996-) • Member, Advisory Board, Clinical Transplantation Proceedings (~1994-~2000) • Member, Advisory Board, Saudi Bulletin of Transplantation and Kidney Diseases (~1994-) • Editor-in-Chief, Sultan Qaboos Journal of Scientific Research (Medical Sciences) ( 1997-2000) Also 8
  9. 9. Curriculum Vitae, Daar AS Occassional Reviewer for, among others: Bioethics, Clinical Transplantation Proceedings, Journal of Medical Ethics, Transplant Intenational, Transplantation, Transplantation Proceedings, World Journal of Surgery, Biomedcentral Ethics, American Journal of Transplantatio II. Research Awards Training Awards Period Granting Agency Title of Grant Amount Role 1989-92 Medical Research Training Fellowship Council of Great Britain Research Grants Period Granting Agency Title of Grant Amount Role 2000-04 Fogarty International U of T MHSc in $1,193,020 US Co-applicant (renewed in Center, National International Bioethics 2004) Institutes of Health 2000-07 Ontario Research Fund U of T Program in Applied $5,620,000 CDN Co-applicant and Ethics and Biotechnology Program Director 2001-05 Genome Canada Canadian Program in $7,200,000 CDN Co-applicant Genomics and Global Health 2002-05 Canadian Institutes for Reconciling growth with $281,802 CDN Co-applicant Health Research ethics: Models of intellectual property protection for biotechnological innovation 2002-04 US Dept. of Energy Representation of $267,000 US Collaborator genomics research among Latin American Laymen and Bioethicists 2002-08 Canadian Institutes for Training Program in $1,860,590 CDN Co-Investigator Health Research Regenerative Medicine -Ethics theme co- leader 2002-04 Genome Canada Bridging the Emerging $2,830,006 CDN Co-applicant Genomics Divide 2003-04 Canadian Institutes for Genomics and Global $62,700 CDN Principal Health Research Health: Developing a Investigator Global CIHR Nework to Address Ethical, Policy, and Regulatory Issues 2003-07 Social Sciences and Modeling Agricultural $2,989,500 CDN Co-Investigator Humanities Research Biotechnology Intellectual 9
  10. 10. Curriculum Vitae, Daar AS Council, Initiative on the Property Protection New Economy, Collaborative Research Initiative 2004-06 Canadian Institutes for Ethical Challenges in the $202,850 CDN Co-Principal Health Research Preparedness and Investigator Response for SARS: An Interdisciplinary Research Study 2004-06 Canadian Institutes for Authorization and $79,000 CDN Co-Investigator Health Research Databases 2004-06 Canadian Institutes for Compelling Values: $38,807 CDN Co-Investigator Health Research Privacy, Access to Data & Health Research Competition 2005 Bill & Melinda Gates Summary Report of $179,395 US Co-investigator Foundation Ethical, Social and Cultural Issues Arising in the Grand Challenges for Global Health 2005 Bill & Melinda Gates (Contract) : Review of $36,000 US Contractee Foundation Grand Challenges in Global Health projects for Ethical, Social and Cultural Issues 2005-06 Canadian Institutes for Leveraging Canadian $56,886 CDN Co-investigator Health Research health research through partnerships with developing countries: A study on collaboration in health biotechnology 2005-09 Canadian Institutes for RMEthnet: "Regenerative $1,500,000 CDN Principal Health Research Medicine: Ethical, Investigator Environmental, Economic, Legal and Social Issues Network" 2005-09 Bill & Melinda Gates Ethical, Social, and $10,000,000 US Co-Principal Foundation Cultural Program for the Investigator Grand Challenges in Global Health Initiative 2005-09 Ontario Research Fund Strengthening the Role of $950,000 CDN Co-Principal Genomics and Global Investigator Health 2006-09 Canadian Institutes for Ethics and pandemic $150,000.00 Co-investigator Health Research planning: Engaging the CDN voices of the public 2006-10 Genome Canada Quantum Dot Diagnostics: $9,300,000 CDN Co-applicant through Simultaneous Genomic Ontario Genomics and Proteomic Profiling of Insitute Multiple Pathogens at 10
  11. 11. Curriculum Vitae, Daar AS Point-of-Care 2006-10 Genome Canada Strenthening the Role of $10,200,000 CDN Co-Principal through Ontario Genomics and Global Investigator Genomics Institute Health 2006-11 Ontario Research Fund From disease gene $14,463,000 Collaborator mapping to clinical CDN (until 2008) practice – a provincial program in clinical genomics 2008-12 Bill & Melinda Gates Ethical, Social, Cultural $ 2,992,320 US Principal Foundation and Commercialization Investigator (ESC2) Program for Water-Efficient Maize for Africa (WEMA) Major Current Research Interests 1. Life Sciences and Technology Innovation in Emerging Economies (focus on technologies, policies and role of the private sector in China, India, Brazil, South Africa) 2. Science and Technology Innovation in Emerging Economies (focus on institutional development – Life Science Convergence Innovation Centres, in Tanzania, Uganda, Rwanda and Ghana) 3. Grand Challenges in global health issues (e.g. chronic non-communicable diseases- cardiovascular diseases, chronic pulmonary diseases, type 2 diabetes, some cancers; new study being launched on global mental health in collaboration with the National Institute of Mental Health at NIH) 4. Ethical, social, cultural and commercialization issues program- study of issues arising in the 500 million $ Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation 5. Ethical, legal and social issues arising from other global health programs of the Bill and Melinda Gates Foundation (e.g. our social audit program for the Water Efficient Maize for Africa project 6. Human genomic variation studies and initiatives in developing countries 7. Research related to the new Grand Challenges Canada initiative STUDENTS/RESEARCHERS SUPERVISED OR CO-SUPERVISED MSc Students at University of Toronto Current: 1. Mark Messih: Ethical Issues of Neurogenerative Medicine in Emerging Economies – A look at India.[Primary Supervisor] 2. Marian Adly: Limiting the collateral damage of SARS: Priority-setting and public health crises [Thesis committee member] Recently completed: 3. Pam Kolopack: Issues of Patient Safety and Research Integrity in Innovative Clinical Trials (MSc Primary Supervisor). Successfully defended thesis in April 2008. 11
  12. 12. Curriculum Vitae, Daar AS 4. Heather Greenwood: Regenerative Medicine for Developing Countries (Primary Supervisor). Successfully defended thesis in June 2006. 5. Andrew Taylor: Developing Policy Options for Canada’s 5% of RD Expenditure Commitment for Development (Thesis committee member). Successfully defended thesis 2005. 6. Jocelyn Mackie: Bioscience Business Ethics (Thesis committee member). Thesis successfully defended in 2004. 7. Fabio Salamanca-Buentello: Nanotechnology for Development (Thesis committee member) Successfully defended thesis in September 2006Marion Motari. MSc thesis successfully defended November 2003. PhD Students at University of Toronto Current: 1. Rahim Rezaie. Working on Private-sector health biotech development in the emerging economies of Brazil, India and China. Successfully converted from MSc to PhD in 2007[Thesis committee member] 2. Billie-Jo Hardy. Working under Human Genome Variation Project entitled “Adoption of Genotyping Technologies for Health in India and Economic Sovereignty [Primary Supervisor]. Converting from MSc to PhD on June 3, 2008. 3. Fabio Salamanca-Buentello. PhD Student [Thesis committee member]. 4. Kenneth Simiyu. PhD Student working on the study investigating the role of health biotechnology innovation systems in selected African countries. [Thesis Committee Member] 5. Kadia Petricca. PhD Student working on developing and pilot-testing guidelines for improving priority setting at the meso and macro levels in Ethiopia, Tanzania and Zambia. [Thesis Committee Member] 6. Dominique McMahon. Regenerative Medicine innovation in emerging economies: A comparative case study of China, Brazil and India [Primary Supervisor] 7. Zahava Rosenberg: Priority Setting for Genomics Technologies [Thesis committee member] 8. Bram de Jonge (Wageningen University and Research Center): Benefit Sharing of Plant Genomics [Thesis Committee Member] 9. Sara Albader, PhD Student at IMS working under the private Sector team researching the role of the private sector in addressing South Africa's health needs through biotechnology (2006-) [Co- Primary Supervisor]. Successfully converted from MSc to PhD in 2007. 10. Monali Ray. “A Case Study on Canada-India Collaboration in Health Biotechnology”. Successfully converted from MSc to PhD. [Primary Supervisor] Recently Completed: 11. Robert Williams: Phenomenology of SARS at a Toronto Hospital (Primary Supervisor). Successfully defended his thesis in June 2007. 12
  13. 13. Curriculum Vitae, Daar AS 12. Robin Hayeems: “Appraisal of Informed Consent and Genetic Databases: An Exploration of the Authorization Model” [Thesis committee member]. Successfully defended her thesis in April 2007. 13. Jeff Nisker: Public Engagement on Genetic Testing Issues through Plays (Primary Supervisor). Successfully defended his thesis in January 2005 Research Assistants/Associates and Post-Doctoral Fellows: 1. Haeli Goertzen [Research Assistant – September 2003-January 2004] 2. Rosario Isasi [Post-doctoral Fellow – 2002-03] 3. Robyn Kennedy [Research Assistant – January-April 2004] 4. Zahra Merali [Post-doctoral Fellow – 2002-03, seconded to WHO; Consultant on PhD thesis, started September 2001, now in law school] 5. Halla Thorsteinsdóttir [Senior Research Associate] 6. Alyna Smith [Research Assistant, seconded to WHO in Geneva, now working with the IP Commission at WHO, Geneva] 7. Charoula Tsamis [Research Assistant 2003-05] 8. Deepa L. Persad (Research Assistant 2003 - October 2005; Program Research Coordinator November 2005 - Present) 9. Archana Bhatt [Research Assistant 2004-05] 10. Uyen Quach [Research Assistant 2003-04] 11. Jason Kuhar [Research Assistant 2004-05] 12. Christina Salmon [Research Assistant 2003-04] 13. Cheryl Cline [Research Assistant/post-doctoral fellow 2003-05] 14. Sarah Frew [Post-doctoral fellow] 15. Tara Acharya [Post-doctoral fellow 2002-03] 16. Christopher McDougal [Research Assistant] 17. Erin Court [Research Assistant] 18. Béatrice Séguin [Post-doctoral fellow] 19. Monali Ray [Research Assistant 2005-2006] 20. Dilnoor Panjwani (Research Assistant 2005 - 2006) 21. Anna Dabu (Research Assistant 2005-2006) 22. Billie-Joe Hardy (Research Assistant 2006) 23. Ronak Shah (Research Assistant, Project Coordinator May 2007-Present) 24. Maya Maliakkal (Research Assistant April 2007-2008) 25. Mark Messih (Research Assistant – September 2007-2008) 26. Fiona Thomas (Research Assistant – September 2007-Present) 27. Victor Liu (Research Assistant – September 2007- Present) 13
  14. 14. Curriculum Vitae, Daar AS 28. Natasha Bhogal (Research Assistant - September 2007- November 2008) 29. Christina Melon (Research Assistant, April 2007 – present) 30. Sina Zere (Research Assistant January 2008-) 31. May Sanaee (Research Assistant January 2008 – September 2008) 32. Renaud Boulanger (Research Assistant, September 2008 – present) 33. Jennifer Heys (Research Assistant, April 2008- present) 34. Myra Khan (Research Assistant, December 2008- present) Past Summer Students: 1. Graeme Bancroft [Summer Student] 2. Isaac Filate [Summer Student, supervised independent study] 3. Jennifer Lam [Supervisor of Senior Research Paper – April 2002-June 2003] 4. Djimms Martinus [Summer Student] 5. Katherine MacDonald [Summer Student] 6. Erin McFadden [Summer Student] 7. Anisa Mnyusiwalla [Summer Student] 8. Martin Tierney [Summer Student] 9. Puja Sahni [Summer Student] 10. Shauna Nast 11. Alex Bite [Summer Student] 12. Leah State [Summer Student] 13. Winnie Siu [Summer Student] 14. Curtis Chin [Summer Student] 15. James Renihan [Summer Student] 16. Ilana Cohen [Summer Student] 17. Susan Dubbin 2006 Summer Students and their Projects 1. Amy Teper - Nanotechnology; WaterEngage 2. Kelsee Stephenson - Nanotechnology; WaterEngage 3. Samina Essajee - Human Genomic Variation 4. Emma Cohen - Grand Challenges in Global Health ESC Program 5. Dilzayn Panjwani - Grand Challenges in Global Health ESC Program 6. Joshua Ramjist - Private Sector Development 7. Jennifer Heys - Private Sector Development 8. Jennifer Chadder - South-South Collaboration 14
  15. 15. Curriculum Vitae, Daar AS 9. Michelle Li - South-South Collaboration 10. Gajen Perry - South-South Collaboration 11. Gunjeet Minhas - OxHA Grand Challenges; WaterEngage 2007 Summer Students 1. Howard Choi – ESC Community Engagement 2. Miry Choi – ESC Product Development and MaRS Africa 3. Nidhee Jadeja – Human Genome Variation 4. Michelle Li – South to South Collaboration and Private Sector 5. Miranda Lin – MaRS Africa 6. Kelvin Lui - ESC Public Engagement 7. Christina Melon - South to South Collaboration 8. Mark Messih – Neuro-Regenerative Medicine 9. Jessica Mustachi – Grand Challenges Chronic Non-Communicable Diseases and Working Groups 10. Gabriel Sin – Regenerative Medicine China 11. Fiona Thomas – MaRS Africa 12. Maya Maliakkal – Private Sector 13. Insiya Essajee - Private Sector 14. Josh Ramjist - Private Sector 2008 Summer Students 1. Alexander Lim – Collaborations 2. Don Li – Private Sector 3. Jasmin Fernandez – Product Development 4. Kim Le – Product Development 5. Marilyn Heymann – MaRS Africa 6. Menaka Pulandiran – MaRS Africa 7. Rabia Tahir – Human Genomic Variation 8. Renaud Boulanger – Community Engagement / Advisory Service 9. Michael Kuziw – WEMA / Advisory Service 10. Melinda Treurnicht-Naylor – WEMA / Engage 2009 Summer Students 1. Debbie Wang - WEMA 2. Kathryn Barber - WEMA 15
  16. 16. Curriculum Vitae, Daar AS 3. Gillian Christie – SENTINEL 4. Justin Chakma - Health Product Development in Low-Resource Settings 5. Arisa Goldstone - Community Engagement 6. Hima Batavia – Product Development 7. Mazen Zehairi - Community Engagement Publications 16
  17. 17. Curriculum Vitae, Daar AS C. PUBLICATIONS Doctor of Philosophy ( D.Phil) Thesis, Univeristy of Oxford Daar AS. Studies with monoclonal antibodies on the potential clinical value of human cell membrane differentiation antigens. Doctor of Philosophy Degree thesis, University of Oxford, 1982. Books 1. Gough MH, Gear MW, Daar AS. Plain X-Ray Diagnosis of the Acute Abdomen. Oxford: Blackwell Scientific Publishers, 1986. ISBN 0632-01432-6 2. a. Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publishers, 1987. ISBN 0-632-01512-8 b. Daar AS, ed. Mercatori Tumerali nella Pratica Clinica: Concetti ed Applicazioni. (Italian Translation of Tumour Markers in Clinical Practice: Concepts and Applications.) Salerno, 1998. ISBN 0-632-01512-8 3. Gutmann T, Daar AS, Sells RA and Land W, Eds. Ethical, Legal And Social Issues In Organ Transplantation. Munich: PABST Science Publishers, 2004. ISBN 3-89967-017-5 (Europe), ISBN 1-59326-063-6 (USA) 4. Finegold DL, Bensimon CM, Daar AS, Eaton M, Goddard B, Knoppers BM, Mackie JE, Singer PA. BioIndustry Ethics. San Diego: Elsevier Academic Press, 2005. ISBN 0-1236-9370-5 5. Castle D, Cline C, Daar AS, Singer PA, Tsamis C. Science, Society, and the Supermarket- The Opportunities and Challenges of Nutrigenomics. John Wiley and Sons, Inc., November 2006. 176 pp. ISBN: 0-471-77000-0 Forthcoming: 6. Daar AS, Singer PA. From Lab to Village. To be published by Random House in 2010 Reports in Book Form Reports in Book Form 1. Acharya T, Daar AS, Thorsteinsdóttir H, Martin DK, Smith AC, Nast S, Singer PA. Top 10 Biotechnologies for Improving Health in Developing Countries. Report: Program in Applied Ethics and Biotechnology- Canadian Program on Genomics and Global Health. University of Toronto Joint Centre for Bioethics. Foreword by Joshua Lederberg. 2002. 2. Acharya T, Daar AS, Dowdeswell E, Singer PA, Thorsteinsdóttir H. Genomics and Global Health. A Report of the Genomics Working Group of the Science and Technology Innovation Task Force of the United Nations Millennium Development Project Science and Technology Innovation Task Force, October 2004. In: UN Millennium Project Task Force on Science, Technology and Innovation – Genomics and Nanotechnology Working Group (Juma C, Yee- Cheong L, eds.). Innovation: Applying Knowledge in Development. Achieving the Millennium Development Goals. London: Earthscan, 2005. ISBN 1-84407-218-5 17
  18. 18. Curriculum Vitae, Daar AS 3. Caulfield T, Daar AS, Hamet P, Kroeger A, Ling V, McPherson A, Morrow J, Slater B, Closson T. A Report of the Expert Working Party on Human Genetic Materials, Intellectual Property and the Health Sector presented to Canadian Biotechnology Advisory Committee (CBAC). Human Genetic Materials: Making Canada’s Intellectual Property Regime Work for the Health of Canadians. October 2005. 4. Juma C (Co-Chair), Serageldin I (Co-Chair), Daar AS, member of Panel. “Freedom to Innovate: Biotechnology in Africa’s Development. Report of the High-Level African Panel on Modern Biotechnology. African Union. January 2007 Weblink: http://www.nepadst.org/doclibrary/pdfs/biotech_africarep_2007.pdf 5. Gold, Edward Richard, Adams, Wendy A., Bernier, Louise , Bubela, Tania, Cassivi, Luc, Castle, David, Cleret de Langavant, Ghislaine, Martin Cloutier, L., Daar AS., Delerue, Hélène , Glass, Amy Jocelyn, Henry, Elisa, Knowles, Lori, Morin, Jean-Frédéric, Piper, Tina and Smith, Pamela J.D. Toward a New Era of Intellectual Property: From Confrontation to Negotiation - A Report by the International Expert Group on Biotechnology, Innovation and Intellectual Property(September 9, 2008). Available at SSRN: http://ssrn.com/abstract=1260099 Journal Publications (Peer Reviewed) 1. Morris PJ, Ting A, Daar AS, Oliver D. B-cell alloantibodies and renal allografts. [Research Communication.] Lancet 1976 Aug 7;2(7980):312-3. 2. Daar AS, Morris PJ, Oliver DO. Leucocytosis is not a manifestation of rejection. British Medical Journal 1977 Dec 17;2(6102):1570-1. 3. Gray D, Shepherd H, Daar AS, Oliver DO, Morris PJ. Oral versus intravenous high-dose steroid treatment of renal allograft rejection: The big shot or not? Lancet 1978 Jan 21;1(8056):117-8. 4. Daar AS, Finch RA. Graft avulsion: An unreported complication of axillofemoral bypass grafts. British Journal of Surgery 1978 Jun;65(6):442. 5. Daar AS. Neurilemoma of femoral nerve-a possible pitfall. British Journal of Clinical Practice 1981 Jun;35(6):240-1. 6. Daar AS, Merrill CR, Moolla SM, Clarke TN. Rectal examination and acid phosphatase: Evidence for persistence of a myth. British Medical Journal (Clin Res Ed) 1981 Apr 25;282(6273):1378-9. See also Daar AS. Rectal examination and acid phosphatase. British Medical Journal (Clincial Res Ed) 1981 Jun 20:282(6281):2055. 7. Daar AS, Fabre JW. Organ-specific IgM autoantibodies to liver, heart and brain in man: Generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis. Clinical Experimental Immunology 1981 Jul;45(1):37-47. 8. Daar AS, Ormiston MC. Scrotal Cancer - A notifiable occupational disease. British Journal of Clinical Practice 1981 Jul-Aug;35(7-8):281-2. 18
  19. 19. Curriculum Vitae, Daar AS 9. Daar AS, Fabre JW. Demonstration with monoclonal antibodies of an unusual mononuclear cell infiltrate and loss of normal epithelial membrane antigens in human breast carcinomas. Lancet 1981 Aug 29;2(8244):434-8. Patey Prize Article 10. Daar AS. Acute primary epiploic appendagitis. British Journal of Clinical Practice 1981 Sep;35(9):333-5. 11. Daar AS, Fuggle SV, Ting A, Fabre JW. Anomolous expression of HLA-DR antigens on human colorectal cancer cells. Journal of Immunology 1982 Aug;129(2):447-9. 12. Daar AS, Fuggle SV, Hart DNJ, Dalchau R, Abdulaziz Z, Fabre JW, Ting A, Morris PJ. Demonstration and phenotypic characterisation of HLA-DR positive interstitial dendritic cells widely distributed in human connective tissue. Transplantation Proceedings 1983;15:311-5. 13. Daar AS, Fabre JW. The membrane antigens of human colorectal cancer cells: Demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous express of HLA-DR. European Journal of Cancer and Clinical Oncology 1983 Feb;19(2):209-20. 14. Fuggle SV, Errasti P, Daar AS, Fabre JW, Ting A, Morris PJ. Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys: Differences in HLA- DR staining of tubules among kidneys. Transplantation 1983 Apr;35(4):385-90. 15. Daar AS. Doctor's beliefs and biochemical reality regarding acid phosphatase and rectal examination. Bristol Medico-Chirurgical Journal 1983;24. 16. Meyer D, Daar AS, Casey T, Fabre TW. Localisation of HLA-ABC and HLA-DR antigens in the human cornea: Practical significance for grafting technique and HLA typing. Transplantation Proceedings 1983;15:126. 17. Frostick SP, Collin J, Daar AS, Kettlewell M, Nolan DJ. Non-traumatic intramural haematoma: An unusual cause of duodenal obstruction. British Journal of Surgery 1984 Apr;71(4):313-4. 18. Galbraith KA, Daar AS, Gatter KC, Dunnill MS. Alveolar soft part sarcoma: Ultrastructual and immunohistological studies with monoclonal antibodies. British Journal of Clinical Practice 1984 Apr;38(4):154-6. 19. Rouse T, Daar AS, Collin J. Herniation through an iatrogenic ilial bone defect. British Journal of Clinical Practice 1984 Jun;38(6):231-2. 20. Rouse T, Collin J, Daar AS. Isolated injury to the intestine from blunt abdominal injury. Injury 1984 Sep;16(2):131-3. 21. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 1984 Sep;38(3):287-92. 22. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation 1984 Sep;38(3):293-8. 23. Salahudeen S, Pingle A, Kazi M, Daar AS. Fistulisation of arterio-venous (AV) shunt vasculature in patients on haemodialysis. Emirates Medical Journal 1986;4:121-5. 19
  20. 20. Curriculum Vitae, Daar AS 24. Alfahim A, Daar AS. The first 100 thyroidectomies at Mafraq Hospital: A surgical profile. Emirates Medical Journal 1986;4:205-10. 25. Masri M, Naiem M, Daar AS. Age and dose dependence of cyclosporine G nephrotoxicity in BALB/c mice. Transplantation Proceedings 1987 Feb;19(1-Pt.2):1212-3. 26. Daar AS, Pingle S, Naiem M, Masri MA. Histologic changes in atrophic spleens of mice treated with cyclosporine A. Transplantation Proceedings 1987 Oct;19(5):4329-30. 27. Kazim S, Daar AS. Review of lymph node biopsies at a referral hospital in the UAE. Emirates Medical Journal 1987;5:222-5. 28. Masri MA, Naiem M, Pingle S, Daar AS. Cyclosporine A versus cyclosporine G: A comparative study of survival, hepatotoxicity, nephrotoxicity, and splenic atrophy in BALB/c mice. Transplant International 1988 Apr;1(1):13-8. 29. Dalchau R, Daar AS, Fabre JW. The human Thy-1 molecule. Immunological Series 1989;45:185-96. 30. Masri MA, Naiem M, Daar AS. Immunopathological changes in the spleen of BALB/c mice treated with either cyclosporine A or cyclosporine G. Transplantation Proceedings 1989 Feb;21(1-Pt.1):952-3. 31. Daar AS. Ethical issues -- a Middle East perspective. Transplantation Proceedings 1989 Feb;21(1-Pt.2):1402-4. 32. Flanagan BF, Dalchau R, Allen AK, Daar AS, Fabre JW. Chemical composition and tissue distribution of the human CDw44 glycoprotein. Immunology 1989 Jun;67(2):67-75. 33. Daar AS, Sells RA. Living non related donor renal transplantation -- A reappraisal. Transplantation Review 1990;4:128-40. 34. Daar AS, Salahudeen AK, Pingle A, Woods HF. Ethics and commerce in live donor renal transplantation: Classification of the issues. Transplantation Proceedings 1990 Jun;22(3):922-4. 35. Salahudeen AK, Woods HF, Pingle A, Nur-El-Huda Suleyman M, Shakuntala K, Nandakumar M, Yahya TM, Daar AS. High mortality among recipients of bought living-unrelated donor kidneys. Lancet 1990 Sep 22;336(8717):725-8. 36. Gyasi HK, Zarroug AW, Matthew M, Joshi R, Daar AS. Anaesthesia for renal transplantation in sickle cell disease. Canadian Journal of Anaesthesia 1990 Oct;37(7):778-85. 37. Daar AS. Renal transplantation in Islam: The basis for recent legal opinions. Emirates Medical Journal 1990;8:1-3. 38. Daar AS. The case for using living non-related donors to alleviate the world wide shortage of cadaver kidneys for transplantation. Annals of the Academy of Medicine, Singapore 1991 Jul;20(4):443-52. 39. Daar AS. Organ donation -- world experience; The Middle East. Transplantation Proceedings 1991 Oct;23(5):2505-7. 20
  21. 21. Curriculum Vitae, Daar AS 40. Reacher MH, Munoz B, Alghassany A, Daar AS, Elbualy M, Taylor HR. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Archives of Ophthalmology 1992 May;110(5):667-74. 41. Daar AS, Lim S, Thompson JF. First International Congress on Transplantation in Developing Countries. Transplantation Proceedings 1992;24:1645-2134. (Guest Editor) 42. al-Dhahry SH, Aghanashinikar PN, al-Hasani MK, Buhl MR, Daar AS. Antibodies to hepatitis C virus in Omani patients with renal disease. Transplantation Proceedings 1992 Oct;24(5):1938-9. 43. Naiem M, Amiry N, Hag A, Akhter S, Daar AS. Suppression of in vitro lymphocyte reactivity to PHA by lysates from human placentae: Lack of correlation with gravida number. Transplantation Proceedings 1992 Oct;24(5):1654-5. 44. Naiem M, Amiry N, Akhter S, Daar AS. Identification and characterisation of two glycoproteins of molecular weights 60 and 180 kd from human multigravid placenta having strong in vitro immunosuppressive activity. Transplantation Proceedings 1992 Oct; 24(5):1657-8. 45. Pingle A, Shakuntala RV, Zahir MB, Shanawaz M, Masri MA, Hayes K, Daar AS, Dhawan IK. Factors responsible for elimination of potential kidney donors in a living-related donor kidney transplant program. Transplantation Proceedings 1992 Oct;24(5):1889-90. 46. Aghanashinikar PN, al-Dhahry SH, al-Marhuby HA, Buhl MR, Daar AS, Al-Hasani MK. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases. Transplantation Proceedings 1992 Oct;24(5):1913-4. 47. Pingle A, Shakuntala RV, Shanawaz M, Zaheer MB, Yassin I, Masri M, Daar AS, Dhawan IK. Impact of renal transplantation on liver disease of diverse etiology. Transplantation Proceedings 1992 Oct;24(5):1916. 48. Daar AS. Nonrelated donors and commercialism: A historical perspective. Transplantation Proceedings 1992 Oct;24(5):2087-90. 49. Daar AS. Rewarded gifting. Transplantation Proceedings 1992 Oct;24(5):2207-11. 50. Kabir S, Aebersold R, Daar AS. Identification of a novel 4 kDa immunoglobulin-A-binding peptide obtained by the limited proteolysis of jacalin. Biochimica et Biophysica Acta 1993 Feb 13;1161(2-3):194-200. 51. Al Dhahry SH, Aghanashinikar PN, al-Hasani MK, Buhl MR, Daar AS. Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease. Infection 1993 May- Jun;21(3):164-7. 52. Daar AS. Commerce in transplantable human kidneys. Revista Espanola de Trasplantes 1993;2:58-61. 53. Aghanashinikar PN, Daar AS, Marhuby H, Woods HF, Nandakumar M, Yaqoob M, White AG, Albusaidi QM, al Hassani MK. Omani experience with a heterogeneous group of kidney transplant recipients over a 10-year period. Transplantation Proceedings 1993 Jun;25(3):2359-60. 21
  22. 22. Curriculum Vitae, Daar AS 54. Al Dhahry SHS, Al Marhuby HA, Prabakar N, Buhl MR, Daar AS, Al Hassani MK. Prevalence of hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal disease: A seroprevalence study. Annals of Saudi Medicine 1994;14:312-5. 55. Daar AS. Living-organ donation: Time for a donor charter. Clinical Transplantation 1994:376-80. 56. Daar AS. Xenotransplantation and religion: The major monotheistic religions. Xeno 1994;2:61-4. 57. Daar AS. Rampant commercialism and "rewarded gifting": Defining the acceptable. Nefrologia 1994;14:74-7. 58. Daar AS. The body, the soul and organ donation: beliefs of the major world religions. Nefrologia 1994;14:78-81. 59. Kabir S, Daar AS. The composition and properties of jacalin, a lectin of diverse applications obtained from the jackfruit (Artocarpus heterophyllus) seeds. Immunological Investigations 1994 Apr;23(3):167-88. 60. Venkataram MN, White AG, Leeny WA, al Suwaid AR, Daar AS. HLA antigens in Omani patients with vitiligo. Clinical and Experimental Dermatology 1995 Jan;20(1):35-7. 61. Daar AS, Mohsin N, Chandy M, Marhubi H. Current status of organ transplantation in the Sultanate of Oman. Bulletin of the Asian Society of Transplantation 1995;3:2021. 62. Ahmed ISA, Al Gharibi KN, Daar AS, Kabir S. The composition and properties of date proteins. Food Chemistry 1995;53:441-6. 63. Kabir S, Daar AS. Maturation of immunoglobulin-A binding proteins in the seeds of jackfruit. Biochemistry and Molecular Biology International 1995 Apr;35(5):1049-57. 64. Kabir S, Ahmed IS, Daar AS. The binding of jacalin with rabbit immunoglobulin G. Immunological Investigations 1995;24(5):725-35. 65. Kabir S, Grant C, Daar AS. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma. Cancer Letters 1995;95:207-12. 66. Al Hassani MK, Sharma U, Mohsin N, Aghanashinikar P, al Maiman Y, Kumar MN, Daar AS. Pregnancy in renal transplantation recipients: Outcome and complications in 44 pregnancies. Transplantation Proceedings 1995 Oct;27(5):2585. 67. Daar AS. Developments in immunosuppressive therapy. Transplantation Proceedings 1995 Oct;27(5):2571-5. 68. White AG, Al Riyami HA, Kuchipudi P, Daar AS. Immunoglobulins, Immunoglobulin G subclasses and complement in adult Omanis. Annals of Saudi Medicine 1996. 69. Pradeep JK, Kehinde EO, Daar AS. Symptomatic response to ascorbic acid. British Journal of Urology 1996 Feb;77(2):319-20. 22
  23. 23. Curriculum Vitae, Daar AS 70. Grant C, Daar AS. Preventing medical negligence in the Gulf region. World Health Forum 1996;17(3):1-4. 71. Marshall PA, Thomasma DC, Daar AS. Marketing human organs: The autonomy paradox. Theoretical Medicine 1996 Mar;17(1):1-18. 72. Shaheen FAM, Albar M, Daar AS. Cadaveric organ transplantation in developing countries: Socio-economic, religious and ethical issues. Pakistani Medical Journal 1996. 73. Agarwal AK, White AG, Ali M, Leheny WA, Daar AS. HLA antigens in an Omani population with dilated cardiomyopathy. International Journal of Cardiology 1996 Jul 5;55(1):29-32. 74. Daar AS. An emerging transplant force -- Developing countries: Middle East and the Indian subcontinent. Transplantation Proceedings 1997 Feb-Mar;29(1-2):1577-9. 75. White AG, Bogh J, Leheny W, Kuchipudi P, Varghese M, al Riyami H, al Hashmi S, Daar AS. HLA antigens in Omanis with blinding trachoma: Markers for disease susceptibility and resistance. British Journal of Ophthalmology 1997 Jun;81(6):431-4. 76. Rothman DJ, Rose E, Awaya T, Cohen B, Daar AS, Dzemeshkevich SL, Lee CJ, Munro R, Reyes H, Rothman SM, Schoen KF, Scheper-Hughes N, Shapira Z, Smit H. The Bellagio Task Force Report on Transplantation, Bodily Integrity, and the International Traffic in Organs. Transplantation Proceedings 1997 Sep;29(6):2739-45. 77. Hoffenberg R, Lock M, Tilney N, Casabona C, Daar AS, Guttmann RD, Kennedy I, Nundy S, Radcliffe-Richards J, Sells RA [International Forum for Transplant Ethics]. Should organs from patients in permanent vegetative state be used for transplantation? Lancet 1997 Nov;350:1320-1. 78. Harris PF, Abu-Hijleh MF, Grant CS, Daar AS. Brachial plexus palsy and spinal subarachnoid pneumatosis following trauma. Clinical Anatomy 1997;10(6):419-23. 79. Daar AS. Ethics of xenotransplantation: Animal issues, consent, and likely transformation of transplant ethics. World Journal of Surgery 1997 Nov-Dec;21(9):975-82. 80. Bhargava D, Bhusnurmath S, Daar AS. Chondroid syringoma of the nose: report of a case. Journal of Laryngology and Otology 1997 Sep;111(9):862-4. 81. Daar AS. The response to the challenge of organ shortage in the Middle East region: A summary. Transplantation Proceedings 1997 Dec;29(8):3215-6. 82. Daar AS. The New Indian Law for Organ Transplantation: One More Step Against Traffic of Organs. Bulletin of the Catalan Transplantation Society 1997;1(1):16. 83. Daar AS, Kolbe RJ. Ethics, Equity and the Health-for-All Strategy: The Missing Dimensions. World Health Forum 1997;18(2). 84. Daar AS, Land W, Yahya TM, Schneewind K, Gutmann T, Jakobsen A. Living donor renal transplantation: Evidence-based justification for an ethical option. Transplant Reviews 1997;11:95-109. 85. Daar AS. Brain death, organ donation and commerce in organs -- features of the new Indian law. Bulletin of the Catalan Transplantation Society 1997. 23
  24. 24. Curriculum Vitae, Daar AS 86. Daar AS, Shaheen FAM, Al Bar M, Al Khadher A. Transplantation in Developing Countries -- Issues Bearing Upon Ethics. Pakistani Journal of Medical Ethics 1997;2(4):4-7. 87. Kennedy I, Sells RA, Daar AS, Guttmann RD, Hoffenberg R, Lock M, Radcliffe-Richards J, Tilney N [International Forum for Transplant Ethics]. The case for "presumed consent" in organ donation. Lancet 1998 May 30;351:1650-2. 88. Daar AS, Marshall P. Culture and psychology in organ transplantation. World Health Forum 1998;19(2):124-32. 89. Radcliffe-Richards J, Daar AS, Guttmann RD, Hoffenberg R, Kennedy I, Lock M, Sells RA, Tilney N [International Forum for Transplant Ethics]. The case for allowing kidney sales. Lancet 1998 Jun 27;351:1950-2. 90. Daar AS. Quest for organ donors: development of transplant ethics. Transplantation Proceedings 1998 Nov;30(7):3616. 91. Daar AS. Prospects of organ sharing and strategies for increasing transplants in Asia. Transplantation Proceedings 1998 Nov;30(7):3649. 92. Daar AS. An overview of transplantation issues in the Middle East. Transplantation Proceedings 1998 Nov;30(7):3638. 93. Marshall PA, Daar AS. Cultural and psychological dimensions of human organ transplantation. Annals of Transplantation 1998;3(2):7-11. 94. Daar AS. Societal Issues in Organ Transplantation. Annals of Transplantation 1998;3(2):5-6. 95. Daar AS. Paid organ donation: The Grey Basket concept. Journal of Medical Ethics 1998 Dec;24(6):365-8. 96. Daar AS. Analysis of factors for the prediction of the response to xenotransplantation. Annals of the New York Academy of Sciences 1998 Dec 30;862:222-33. 97. White AG, Leheny W, Kuchipudi P, Varghese M, Al Riyami H, Al Hashmi S, Daar AS. Histocompatibility antigens in Omanis: Comparison with other Gulf populations and implications for disease association. Annals of Saudi Medicine 1999;19:193-6. 98. Daar AS. The evolution of organ transplantation in the Middle East. Transplantation Proceedings 1999 Feb-Mar;31(1-2):1070-1. 99. Mohsin N, Daar AS. Immunosuppressive drugs in renal transplantation. Kidney Forum 1999;1(2):13-7. 100.Daar AS. Animal-to-human organ transplants -- a solution or a new problem? Bulletin of the World Health Organization 1999;77(1):54-61. 101.Daar AS. Living non-related kidney transplantation: Time to be taken seriously. Transplantation Proceedings 1999 Jun;31(4):1769-71. 24
  25. 25. Curriculum Vitae, Daar AS 102.Daar AS. Xenotransplantation: Informed consent/contract and patient surveillance. Biomedical Ethics 1999;4(3):87-91. 103.Grant CS, Al-Kindy N, Machado N, Daar AS. Laparoscopic Surgery at Sultan Qaboos University Hospital. SQU Journal of Scientific Research - Medical Sciences 2000;1:115-19. 104.Scrimgeour EM, Daar AS. Schistosomiasis: Clinical relevance to surgeons in Australasia and diagnostic update. Australian and New Zealand Journal of Surgery 2000 Mar;70(3):157-61. 105.Daar AS. Xenotransplantation und die mittelostlichen Religionen. Nieren und Hochdruckkrankheiten (Official Journal of the Gesellschaft fur Nephrologie). 2000 Mar;29:119-27. 106.Daar AS. Cultural and societal issues in organ transplantation: Examples from different cultures. Transplantation Proceedings 2000 Nov;32(7):1480-1. 107.Daar AS. Xenotransplantation and cloning: Working with the World Health Organization to develop ethical guiding principles. Transplantation Proceedings 2000 Nov;32(7):1549-50. 108.Ethics Committee, Human Genome Organization. (Knoppers BM, Chadwick R, Takebe H, Kirby M, Berg K, RenZong Q, Macer D, Cantu J-M, Wertz DC, Murray TH, Daar AS, Verma I, Engels EM) Genetic Benefit Sharing. Science 2000;290:49. 109.Daar AS. Altruism and reciprocity in organ donation: Compatible or not? Transplantation 2000;70:704-5. 110.Williams F, Curran MD, Leheny WA, Daar AS, Middleton D. Characterization of HLA- B*3921 and confirmation of HLA-B*4415, two variant HLA-B alleles identified in the Omani population. Tissue Antigens 2000 Oct;56(4):376-9. 111.Middleton D, Williams F, Meenagh A, Daar AS, Gorodezky C, Hammond M, Nascimento E, Briceno I, Perez MP. Analysis of the distribution of HLA-A alleles in populations from five continents. Human Immunology 2000 Oct;61(10):1048-52. 112.Singer PA, Daar AS. Avoiding frankendrugs. Nature Biotechnology 2000 Dec;18(12):1225. 113.Knoppers BM, Chadwick R, Takebe H, Berg K, Cantu J-M, Daar AS, Engels EM, Kirby M, Macer D, Murray TH, Ren-Zong Q, Verma IC, Wertz DC [Ethics Committee of the Human Genome Organization]. HUGO Urges Genetic Benefit-Sharing. Community Genetics 2000;3:88-92. 114.Hugo Ethics Committee statement on benefit sharing - April 9, 2000. Knoppers BM, Chadwick R, Takebe H, Berg K, Cantu JM, Daar AS, Engels EM, Kirby M, Macer D, Murray TH, Qui RZ, Wertz DC, Verma IC. (HUGO Ethics Committee). Clinical Genetics 2000 Nov;58 (5):364-6. 115.Daar AS, al Khitamy AB. Bioethics for Clinicians: 21. Islamic Bioethics. Canadian Medical Association Journal 2001;164(1):60-3. 25
  26. 26. Curriculum Vitae, Daar AS 116.Daar AS. Southern Mediterranean, Middle East, and Subcontinent organ transplantation activity. Transplantation Proceedings 2001;33(2-1):1993-4. 117.Tilney NL, Guttmann RD, Daar AS, Hoffenberg R, Kennedy I, Lock M, Radcliffe-Richards J, Sells RA, for the International Forum on Transplant Ethics. The New Chimaera: The industrialization of organ transplantation. Transplantation 2001;71:591-3. 118.Daar AS. Choosing Risk-Benefit Analysis or Precautionary Principle as Our Approach to Clinical Xenotransplantation. Graft 2001;4(2):164-6. 119.Williams F, Meenagh A, Darke C, Acosta A, Daar AS, Gorodezky C, Hammond M, Nascimento E, Middleton D. Analysis of the distribution of HLA-B alleles in populations from five continents. Human Immunology 2001;62(6):645-50. 120.Daar AS, Al Khitamy AB. Islamic Bioethics. Pakistan Journal of Medical Ethics 2001; 4(1): 14-8; reprinted from Canadian Medical Association Journal 2001;164:60-3. 121.Singer PA, Daar AS. Harnessing Genomics and Biotechnology to Improve Global Health Equity. Science 2001 Oct;294(5540):87-9. 122.Scrimgeour EM, Ahmed A, Sallam J, Khoul R, Al-Dhahry SHS, Daar AS, El-Khatim HS, Idris MA, Date A. Schistosomiasis in patients in the Sultanate of Oman. Annals of Saudi Medicine 2001;21(3-4):170-3. 123.Dowdeswell E, Daar AS, Singer PA. Getting governance into genomics. Science and Public Policy 2005; 32(6): 497-498 124.Al Alam F, Kehinde EO, Daar AS, Albar MA. The management of a true hermaphrodite in an Islamic country. British Journal of Sexual Medicine 2002;26(1):24-26. 125.Daar AS. Strangers, intimates, and altruism in organ donation. Transplantation 2002 Aug;74(3):424-6. 126.Gold ER, Castle D, Cloutier LM, Daar AS, Smith PJ. Needed: Models of Biotechnology Intellectual Property. Trends in Biotechnology 2002 Aug;20(8):327-9. 127.Daar AS, Thorsteinsdóttir H, Martin DK, Smith AC, Nast S, Singer PA. Top 10 Biotechnologies for Improving Health in Developing Countries. Nature Genetics 2002 Oct;32(2):229-32. 128.Daar AS, Sheremeta L. The Science of Stem Cells: Some Implications for Law and Policy. Health Law Review 2002 Winter;11(1):5-13 129.Dowdeswell E, Daar AS, Singer PA. Bridging the Genomics Divide. Global Governance Journal 2003;9:1-6. 130.Caulfield T, Upshur REG, Daar AS. DNA databanks and consent: A suggested policy option involving an authorization model. BioMedCentral Medical Ethics 2003 Jan;4:E1. Available online at http://www.biomedcentral.com/1472-6939/4/1. 131.Benatar SR, Daar AS, Singer PA. Global Health Ethics: The rationale for mutual caring. International Affairs 2003;79:107-38. 26
  27. 27. Curriculum Vitae, Daar AS 132.Knox-Macaulay H, Ayyaril M, Nusrat N, Daar AS. Colonic pseudo-obstruction in sickle cell disease. Southern Medical Journal 2003 Jan;96(1):93-5. 133.Mnyusiwalla A, Daar AS, Singer PA. “Mind the Gap”: Science and Ethics in Nanotechnology. Nanotechnology 2003;14:R9-13. 134.Thorsteinsdóttir H, Daar AS, Smith RD, Singer PA. Genomics – A Global Public Good? Lancet 2003;361(9361):891-2. 135.Daar AS. Paid Organ Donation and Organ Commerce: Continuing the Ethical Discourse. Transplantation Proceedings 2003 May;35(3):1207-9. 136.Choudhry S, Daar AS, Radcliffe-Richards J, Guttmann RD, Hoffenberg R, Lock M, Sells RA, Tilney N. Unrelated living organ donation: ULTRA needs to go. Journal of Medical Ethics 2003 Jun;29(3):169-70. 137.Wright L, Daar AS. Ethical Aspects of Living Donor Kidney Transplantation and Recipient Adherence to Treatment. Progress in Transplantation 2003 Jun;13(2):105-9. 138.McKneally MF, Daar AS. Introducing New Technologies: Protecting Subjects of Surgical Innovation and Research. World Journal of Surgery 2003 Aug;27(8):930-4; discussion 934-5. Epub 2003 Jun 26. 139.Daar AS, Dowdeswell E, Singer PA. Genome Diplomacy: Canada’s Crucial Role. Policy Options 2003;24(8):56-61. 140.Caulfield T, Sheremeta L, Daar AS. Somatic cell nuclear transfer – how science outpaces the law. Nature Biotechnology 2003 Sep;21(9):969-70. 141.Mohsin N, Marhuby H, Maimani Y, Aghanishankar P, Al-Hassani M, Daar AS. Development of morbid obesity after transplantation in Laurence Moon Biedle syndrome. Transplantation Proceedings 2003 Nov;35(7):2619. 142.Mohsin N, Marhuby H, Maimani Y, Aghanishankar P, Al-Hassani M, Daar AS. Living kidney donation for the mentally impaired: A case report. Transplantation Proceedings 2003 Nov;35(7):2571-2. 143.Daar AS. Xenotransplantation – Recent Scientific Developments and Continuing Ethical Discourse. Transplantation Proceedings 2003 Nov;35(7):2821-2. 144.Varmus H, Klausner R, Zerhouni E, Acharya T, Daar AS, Singer PA. Public Health. Grand Challenges in Global Health. Science 2003 Oct 17;302(5644):398-9. 145.Singer PA, Benatar SR, Bernstein M, Daar AS, Dickens BM, MacRae S, Upshur REG, Wright L, Zlotnik Shaul R. Ethics and SARS: Learning Lessons from Toronto. British Medical Journal 2003;327:1342-4. 146.Daar AS, Sheremeta L. The Science of Stem Cells: Ethical, Legal and Social Issues. Experimental and Clinical Transplantation 2003 Dec;1(2):139-46. 147.Acharya T, Daar AS, Singer PA. Biotechnology and the UN’s Millennium Development Goals. Nature Biotechnology 2003 Dec;21(12):1434-6. 27
  28. 28. Curriculum Vitae, Daar AS 148.Smith RD, Thorsteinsdottir H, Daar AS, Gold ER, Singer PA. Genomics knowledge and equity: a global public goods perspective of the patent system. Bulletin Of The World Health Organization 2004 May;82(5):385-9. 149.Acharya T, Kumar NK, Singer PA, Daar AS, Muthuswamy V. Harnessing genomics to improve health in India – an executive course to support genomics policy. BioMedCentral Health Research and Policy Systems 2004 May 19;2(1):1. 150.Gold RE, Adams W, Castle D, Cleret de Langavant G, Cloutier LM, Daar AS, Glass A, Smith PJ, Bernier L. The Unexamined Assumptions of Intellectual Property: Adopting an Evaluative Approach to Patenting Biotechnological Innovation. Public Affairs Quarterly 2004 Oct;18(4):299-344. 151.Daar AS, Bhatt A, Court E, Singer PA. Stem Cell Research and Transplantation: Science Leading Ethics. Transplantation Proceedings, 2004 Oct;36(8):2504-6. 152.Daar AS. Non-heart-beating Donation: ten evidence-based ethical recommendations. Transplantation Proceedings 2004;36(7):1885-7. 153.Daar AS. Paid organ procurement: Pragmatic and Ethical Viewpoints. Transplantation Proceedings 2004;36(7):1876-7. 154.Acharya T, Kennedy R, Daar AS, Singer PA. Biotechnology to Improve Health in Developing Countries. Memórias do Instituto Oswaldo Cruz 2004 Jun;99(4):341-50. 155.Court E, Daar AS, Martin E, Acharya T, Singer PA. Will Prince Charles et al diminish the opportunities of developing countries in nanotechnology? Nanotech Web 2004 Jan 28 http:// nanotechweb.org/articles/society/3/1/1/1. 156.Daar AS, Sahni P, Singer PA. Genomics and Global Health: the work of the University of Toronto Joint Centre for Bioethics. Acta Bioethica 2004;10(2):213-25. 157.Sheremeta L, Daar AS. The case for publicly funded research on ethical, environmental, economic, legal and social issues raised by nanoscience and nanotechnology (NE3LS). Health Law Review 2004;12(3):74-7. 158.Thorsteinsdottir H, Quach U, Martin DK, Daar AS, Singer PA. Introduction: promoting global health through biotechnology. Nature Biotechnol 2004 Dec;22Suppl:DC3-7. 159.Ferrer M, Thorsteinsdottir H, Quach U, Singer PA, Daar AS. The scientific muscle of Brazil's health biotechnology. Nature Biotechnol 2004 Dec;22 Suppl:DC8-12. 160.Thorsteinsdottir H, Saenz TW, Quach U, Daar AS, Singer PA. Cuba--innovation through synergy. Nature Biotechnol 2004 Dec;22 Suppl:DC19-24. 161.Motari M, Quach U, Thorsteinsdottir H, Martin DK, Daar AS, Singer PA. South Africa-- blazing a trail for African biotechnology. Nature Biotechnol 2004 Dec;22 Suppl:DC37-41. 162.Abdelgafar B, Thorsteinsdottir H, Quach U, Singer PA, Daar AS. The emergence of Egyptian biotechnology from generics. Nature Biotechnol 2004 Dec;22 Suppl:DC25-30. 28
  29. 29. Curriculum Vitae, Daar AS 163.Kumar NK, Quach U, Thorsteinsdottir H, Somsekhar H, Daar AS, Singer PA. Indian biotechnology--rapidly evolving and industry led. Nature Biotechnol 2004 Dec;22 Suppl:DC31-6. 164.Zhenzhen L, Jiuchun Z, Ke W, Thorsteinsdottir H, Quach U, Singer PA, Daar AS. Health biotechnology in China--reawakening of a giant. Nature Biotechnol 2004 Dec;22 Suppl:DC13-8. 165.Wong J, Quach U, Thorsteinsdottir H, Singer PA, Daar AS. South Korean biotechnology--a rising industrial and scientific powerhouse. Nature Biotechnol 2004 Dec;22 Suppl:DC42-7. 166.Thorsteinsdottir H, Quach U, Daar AS, Singer PA. Conclusions: promoting biotechnology innovation in developing countries. Nature Biotechnol 2004 Dec;22 Suppl:DC48-52. 167.Merali Z, Boulyjenkov V, Singer PA, Daar AS. The ELSI Genetics Regulatory Resource Kit: A Tool for Policymakers in Developing Countries. Journal of Law, Medicine and Ethics 2004 Winter;32(4):692-700. 168.Isasi RM, Knoppers BM, Singer PA, Daar AS. Legal and Ethical Approaches to Stem Cell and Cloning Research: A Comparative Analysis of Policies in Latin America, Asia, and Africa. Journal of Law, Medicine and Ethics 2004 Winter;32(4):626-40. 169.Acharya T, Daar AS, Thorsteinsdottir H, Dowdeswell E, Singer PA. Strengthening the Role of Genomics in Global Health. PLoS Med. 2004 Dec;1(3):e40. Also reprinted in Rotman Magazine 2005 Winter. 170.Mohsin N, Budrudine M, Pakkyara A, Amitabh J, Daar AS. High Incidence of Early Post Transplant Diabetes Mellitus (PTDM) in an Omani Population. Transplant. Proc. 2005 Sep;37(7):2911-2. 171.Mohsin N, Pakkyara A, Budrudine M, Obaid F, Amitabh J, Daar AS. Low Tacrolimus Dose Requirements in Renal Transplant Recipients in the Omani Population: Implications for Pharmacogenetics? Transplant. Proc. 2005 Sep;37(7):3093-4. 172.Acharya T, Abdur Rab M, Singer PA, Daar AS. Harnessing genomics to improve health in the Eastern Mediterranean Region - an executive course in genomics policy. Health Res Policy Syst. 2005 Jan 21;3(1):1. 173.Smith AC, Mugabe J, Singer PA, Daar AS. “Harnessing genomics to improve health in Africa” - an executive course to support genomics policy. Health Res Policy Syst. 2005 Jan 24;3(1):2. 174.Bernstein M, Bampoe J, Daar AS. Ethical issues in molecular medicine of relevance to surgeons. Can J Surg. 2004 Dec;47(6):414-21. Review. Erratum in: Can J Surg. 2005 Feb;48(1):48. 175.Daar AS, Singer PA. Pharmacogenetics and Geographical Ancestry: Implications for Drug Development and Global Health. Nature Reviews Genetics 2005 Mar;6(3):241-6. Also reprinted in Global Forum Update on Research for Health 2005;2:118-25. 176.Singer PA, Bhatt A, Frew S, Greenwood H, Persad DL, Salamanca-Buentello F, Seguin B, Taylor AD, Thorsteinsdottir H, Daar AS. The Critical Role of Genomics in Global Health. Global Forum Update on Research for Health 2005;2:113-7. 29
  30. 30. Curriculum Vitae, Daar AS 177.Daar AS. The world health organization resolution on human organ transplantation: will it result in action? Transplantation 2005 Mar 27;79(6):641-2. 178.Kehinde EO, Akanji AO, Mojiminiyi OA, Bashir AA, Daar AS, Varghese R. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men. Prostate Cancer Prostatic Dis. 2005 Mar;8(1):84-90. 179.Wright L, Ross K, Daar AS. The roles of a bioethicist on an organ transplantation service. Am J Transplant. 2005 Apr;5(4 Pt 1):821-6. 180.Salamanca-Buentello F, Persad DL, Court EB, Martin DK, Daar AS, Singer PA. Nanotechnology and the Developing World. PLoS Med. 2005 May;2(5):e97. Epub 2005 Apr 12. 181.Court EB, Daar AS, Persad DL, Salamanca-Buentello F, Singer PA. Tiny technologies for the global good. NanoToday 2005 May; Materials Today Suppl:14-5. 182.Singer PA, Salamanca-Buentello F, Daar AS. Harnessing Nanotechnology to Improve Global Equity. Issues in Science and Technology 2005; Summer:57-64. 183.Benatar SR, Daar AS, Singer PA. Global Health Challenges: The need for an expanded discourse on bioethics. PLoS Med 2005 Jul;2(7):e143. Epub 2005 Jul 26. 184.Kehinde EO, Mojiminiyi OA, Sheikh M, Al-Awadi KA, Daar AS, Al-Hunayan A, Anim JT, Al- Sumai AA. Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men. British Journal of Urology (Internationa)l 2005 Aug;96(3):308-12. 185.Nisker J, Daar AS. Moral Presentation of Genetics-Based Narratives for Public Understanding of Genetic Science and its Implications. Public Understanding of Science 2005; 15(2006):113-23. 186.Thorsteinsdóttir H, Saenz TW, Singer PA, Daar AS. Different Rhythms of Health Biotechnology in Brazil and Cuba. Journal of Business Chemistry 2005 Sep;2(3):99-106. 187.Mohsin N, Budruddin M, Pakkyara A, Darweesh A, Nayyer M, Amitabh J, Daar AS. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus. Exp Clin Transplant 2005 Dec;3(2):366-9. 188.Nisker J, Martin DK, Bluhm R, Daar AS. Theatre as a Public Engagement Tool for Health- Policy Development. Health Policy (78) 2006. pp 258-271. doi. 10.1016/j.healthpol.2005.10.029 189.Persad DL, Quach U, Thorsteinsdóttir H, Salamanca-Buentello F, Singer PA, Daar AS. Enabling Knowledge Societies for Science and Technology in Developing Countries. International Journal of Biotechnology 2006;8(1/2):4-22. 190.Thorsteinsdóttir H, Daar AS, Singer PA, Archambault E, Aranachalam S. Health Biotechnology Publishing Takes-Off in Developing Countries. International Journal of Biotechnology 2006;8(1/2):23-42. 30
  31. 31. Curriculum Vitae, Daar AS 191.Quach U, Thorsteinsdóttir H, Renihan J, Bhatt A, Costa von Aesch Z, Singer PA, Daar AS. Biotechnology Patenting Takes Off in Developing Countries. International Journal of Biotechnology 2006;8(1/2):43-59. 192.Greenwood HL, Thorsteinsdóttir H, Perry G, Renihan J, Singer PA, Daar AS. Regenerative Medicine: New Opportunities for Developing Countries. International Journal of Biotechnology 2006;8(1/2):60-77. 193.Séguin B, State L, Singer PA, Daar AS. Scientific Diasporas as an Option for Brain Drain: Re-circulating Knowledge for Development. International Journal of Biotechnology 2006;8(1/2):78-90. 194.Frew SE, Sammut SM, Siu WW, Daar AS, Singer PA. The Role of the Domestic Private Sector in Developing Countries for Addressing Local Health Needs. International Journal of Biotechnology 2006;8(1/2):91-102. 195.Mackie J, Taylor AD, Daar AS, Singer PA. Corporate Social Responsibility Strategies Aimed at the Developing World: Perspectives from Bioscience Companies in the Industrialized World. International Journal of Biotechnology 2006;8(1/2):103-118. 196.Dowdeswell E, Daar AS, Singer PA. Increasing Human Security through Biotechnology. International Journal of Biotechnology 2006;8(1/2):119-131. 197.Dowdeswell E, Daar AS, Acharya T, Singer PA. Realizing the Promise of Genomics: Exploring Governance. International Journal of Biotechnology 2006;8(1/2):132-141. 198.Singer PA, Daar AS, Salamanca-Buentello F, Court E. Nano-Diplomacy. Georgetown Journal of International Affairs 2006; Winger/Spring:129-37. 199.Mackie JE, Taylor AD, Finegold DL, Daar AS, Singer PA. Lessons on Ethical Decision- Making from the Bioscience Industry. PLoS Medicine 2006 May;3(5):e129. 200.Dowdeswell E, Daar AS, Singer PA. Getting governance into genomics. Science and Public Policy 2005 Dec;32(6):1-2. 201.Kehinde EO, Akanji AO, Memon A, Bashir AA, Daar AS, Al-Awadi kA, Fatinikin T. Prostate Cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. Int. Urol Nephrol. 2006; 38(1): 33-44. 202.Seguin B, Singer PA, Daar AS. Scientific Diasporas. Science. 2006 Jun 16; 312(5780): 1602-3 203.Frew SE, Rezaie R, Sammut S, Ray M, Daar AS, Singer P. 2006. India’s Home-Grown Health Biotechnology Sector at a Crossroads. Nature Biotechnology. 2007; 25 (4): 403-417 204.Greenwood HL, Singer PA, Downey GP, Martin DK, Thorsteinsdóttir H, et al. (2006) Regenerative Medicine and the Developing World. PLoS Med 3(9): e381 doi:10.1371/journal.pmed.0030381 205.Mahroum, S., Eldridge E. and Daar AS. Transnational Diaspora Options: How Developing Countries Could Benefit from their Emigrant Populations. IJMS: International Journal on 31
  32. 32. Curriculum Vitae, Daar AS Multicultural Societies. 2006, vol.8, no.1, pp. 25-42. UNESCO. ISSN 1817-4574. www.unesco.org/shs/ijms/vol8/issue1/art2 206.Daar AS, Scherer SW and Hegele RA (2006) Large scale copy-number variation in the human genome: a time for questions. Nature Reviews Genetics (2006 June) 7: 414-414 doi:10.1038/nrg1884 207.Daar AS. The case for a regulated system of living kidney sales. Nature Clinical Practical Nephrology. 2006 Nov;2(11): 600-1 208.Mohsin N, Nooyi C, Jha A, Budruddin M, Kamble P, Khalil M,, Pakkyarra A, Mohammed E, Ahmed H, Daar AS. Retinal injury as an early manifestation of post-transplant thrombotic microangiopathy: recovery with plasma exchanges and conversion to sirolimus- case report and review of literature. Transplant Proc. 2007 May; 39 (4): 1272-5. 209.Mohsin N, Budruddin M, Kamble P, Khalil M, Pakkyarra A, Jha A, Mohammed E, Ahmed H, Ahmed J, Thomas S, Campistol JM, Daar AS. Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporine to sirolimus. Transplant Proc. 2007 May; 39 (4): 1267-71. 210.Mohsin N, Budruddin M, Khalil M, Pakkyarra A, Jha A, Mohammed E, Kamble P, Ahmed H, Militsala E, Prabhakar NA, Al-Marhuby H, Ahmed J, Daar AS. Donor gender balance in a living-related kidney transplantation program in Oman. Transplant Proc. 2007 May;39(4):803-6. 211.Thorsteinsdottir H, Daar AS, Singer PA. Innovation Cultures in Developing Countries: TheCase of Health Biotechnology. Comparative Technology Transfer and Society. (5) 2; August 2007; 178-201 212.Daar AS, Greenwood HL. A proposed definition of regenerative medicine. Journal of Tissue Engineering and Regenerative Medicine. May/June 2007. Vol 1 (3) pp 179-184 Online Issn. 1932-7005. Print Issn: 1932-6254. DOI: 10.1002/term.20. 213.Singer PA, Taylor AD, Daar AS, Upshur REG, Singh JA, Lavery, JV. Grand Challenges in Global Health: The Ethical, Social and Cultural Program. PLoS Medicine Vol 4, No. 9, e 265. doi:10.1371/journal.pmed.o040265. September 2007. 214.Berndtson K, Daid T, Tracy CS, Bhan A, Cohen ERM, Upshur REG, Singh JA, Daar AS, Lavery JV, Singer PA. Grand Challenges in Global Health: Ethical, Social, and Cultural Issues based on Key Informant Perspectives. PLoS Medicine Vol 4, No. 9, e 268. doi:10.1371/journal.pmed.o040265. September 2007. 215.Bhan AL, Singh JA, Upshur REG, Singer PA, Daar AS. Grand Challenges in Global Health: Engaging Civil Society Organization in Biomedical Research in Developing Countries. PLoS Medicine Vol. 4, No. 9, e272 doi:10.1371/journal.pmed.0040272. 216.Tindana PO, Singh JA, Tracy SC, Upshur REG, Daar AS, Singer PA, Frohlich, J, Lavery JV. Grand Challenges in Global Health: Community Engagement in Research in Developing Countries. PLoS Medicine Vol. 4, No. 9, e273 doi:10.1371/journal.pmed.0040273 217.Singer PA, Berndtson K, Tracy SC, Cohen ERM, Masum H, Daar AS, Lavery JV. A tough transition. Nature. September 2007. Vol 449, 160-163.. 32
  33. 33. Curriculum Vitae, Daar AS 218.Taylor AD, Brook D, Watters D, Dowdeswell E, Daar AS, Singer PA. North-South Partnerships – A study of Canadian Firms. Nature Biotechnology 25(9), 978-9. September 2007. 219.Daar AS, Singer PA, Persad D, Pramming S, Matthews D, Beaglehole R, Bernstein A, Borysiewicz L, Colagiuri S, Ganguly N, Glass R, Finewood D, Koplan J, Nabel E, Sarna G, Sarrafzadegan N, Smith R, Yach D, Bell J. Grand Challenges in Chronic Non-Communicable Diseases. Nature. November 2007. Vol 450, pp. 494-496. 220.Daar AS, Berndtson K, Persad D, Singer PA. How can developing countries harness biotechnology to improve health? BMC Public Health 2007, 7:346 doi:10.1186/1471-2458-7-346. 221.Hugo Statement on Pharmacogenomics (PGx): Solidarity, Equity and Governance. Genomics, Society and Policy. (3)1: 44-47. (2007) ISSN: 1746-5354 222.Singer PA, Court EB, Bhatt A, Frew SE, Greenwood H, Persad DL, Salamanca-Buentello F, Séguin B, Taylor AD, Thorsteinsdottir H and Daar AS. Applying Genomics-related Technologies for Africa’s Health Needs. African Journal of Medicine and Medical Sciences. 2007; 36. Suppl: 7-14 223.Masum H, Daar AS, Albader S, Shah R, and Singer P. Accelerating Health Product Innovation in Sub-Saharan Africa. Innovations (MIT Press). Vol 2 (4) pp. 151-171. Fall 2007. 224.Emerson CI, Daar AS. Defining Conscience and Acting Conscientiously. The American Journal of Bioethics. 2007 Dec; 7 (12): 19-21 225.Frew S, Sammut S, Shore A, Ramjist J, Al-Bader S, Rezaie R, Daar AS, Singer PA. Chinese health biotech and the billion-patient market. Nature Biotechnology. 26, 37-53 (2008). 226.Seguin B, Hardy B, Singer PA, Daar AS. Bidil: Recontextualizing the Race Debate. The Pharmacogenomics Journal. January 2008 8(3): 169-173 227.Séguin, B., Hardy, B. J., Singer, P. A. & Daar, AS Genomic medicine and developing countries: creating a room of their own. Nature Rev. Genet. 9, 487–493 (2008). 228.Land WG, Gutmann T, Daar AS. Emerging Science, Emerging Ethical Issues: Who should Fund Innate Alloimmunity-Supressing Drugs? Acta Chir Belg, 2008, 108, 73-82 229.Singh Jerome, Daar AS. The 20-year African biotech plan. Nature Biotech. 2008 March Vol 26 (3) pp. 272-274. 230.Cohen ER, Masum H, Berndtson K, Saunders V, Hadfield T, Panjwani D, Persad DL, Minhas GS, Daar AS, Singh JA, Singer PA. Public engagement on global health challenges. BMC Public Health. 2008 May 20;8:168. 231.Rezaie R, Frew SE, Sammut SM, Maliakkal MR, Daar AS, Singer PA. Brazilian health biotech--fostering crosstalk between public and private sectors. Nature Biotechnol. 2008 Jun;26(6):627-44. 232.Lander B, Thorsteinsdóttir H, Singer PA, Daar AS. Harnessing stem cells for health needs in India. Cell Stem Cell. 2008 Jul 3;3(1):11-5. 33
  34. 34. Curriculum Vitae, Daar AS 233.Hotez PJ, Daar AS (2008) The CNCDs and the NTDs: Blurring the Lines Dividing Noncommunicable and Communicable Chronic Diseases. PLoS Negl Trop Dis 2(10): e312. doi:10.1371/journal.pntd.0000312 (October 29, 2008) 234.Daar AS, Whyte SR, Abdullah MS, Ching-Li H, Hoffman SL, Martine Berger; TDR Thirty Years On: Taking Stock and Envisioning the Future for the Special Programme for Research and Training in Tropical Diseases. PLoS Negl Trop Dis 2(11): e314. doi:10.1371/journal.pntd.0000314 (November 25, 2008) 235.Hardy, B., Seguin, B., Mukerji, M., Singer PA., Brahmachari, SK., Daar, AS. (2008) From diversity to delivery: the case of the Indian Genome Variation initiative. Nature Reviews Genetics. 9(10): s9-s13 236.Seguin, B., Hardy, B., Singer PA., Daar, AS. (2008) Genomics, public health, and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nature Reviews Genetics. 9(10): s5-s8 237.Hardy, B., Seguin, B., Ramesar, R., Singer PA., Daar, AS. (2008) South Africa: from species cradle to genomic applications. Nature Reviews Genetics 9(10): s19-s22 238.Seguin, B., Hardy, B., Singer PA., Daar, AS. (2008) Universal health care, genomic medicine and Thailand: investing in today and tomorrow. Nature Reviews Genetics 9(10) :s14-s18 239.Seguin, B., Hardy, B., Singer PA., Daar, AS. (2008) Human genomic variation initiatives in emerging economies and developing countries. Nature Reviews Genetics 9(10) :s3-s4 240.Hardy, B., Seguin, B., Goodsaid, F., Jimenez-Sanchez, G., Singer PA., Daar, AS. (2008) The next steps for genomic medicine: challenges and opportunities for the developing world. Nature Reviews Genetics 9(10) :s23-s27 241.Z. R.S. Rosenberg-Yunger, Daar, AS, P. A. Singer, D.K. Martin Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada. Health Policy 87 (2008) 359-368 242.Timothy Caulfield, Stephanie M Fullerton, Sarah E Ali-Khan, Lauara Arbour, Esteban G Burchard, Richard S Cooper, Billie-Jo Hardy, Simrat Harry, Robyn Hyde-Lay, Jonathan Kahn, Rick Kittles, Barbara A Koenig, Sandra S-J Lee, Michael Malinowski, Vardit Ravitsky, Pamela Sankar, Stephen W Scherer, Beatrice Seguin, Darren Shickle, Guilherme Suarez-Kurtz and Daar, AS. Race and ancestry in biomedical research: exploring the challenges. Genome Medicine 1, January 2009. pp 39-46 243.Singer PA and Daar, AS with Sara Al-Bader, Ronak Shah, Ken Simiyu, Ryan E Wiley, Pamela Kanellis, Menaka Pulandiran and Marilyn Heymann: Commercializing African Health Research: Building Life Science Convergence Platforms-Global Forum Update on Research for Health Volume 5 (October 2008) pp 143-150 244.Christina C. Melon, Monali Ray, Sharon Chakkalackal, Michelle Li, Jan E. Cooper, Jennifer Chadder, Wen Ke, Lexuan Li, Magdy A. Madkour, Sahar Aly, Nefertiti Adly, Sachin Chaturvedi, Victor Konde, Daar, AS, Peter A. Singer, Halla Thorsteinsdóttir A Survey of South-North Health Biotech Collaboration: Nature Biotechnology, Number 3, Volume 27 (March 2009) pp: 229-232 34
  35. 35. Curriculum Vitae, Daar AS 245.Singer PA, Daar, AS, How biodevelopment can enhance biosecurity. Bulletin of the Atomic Scientists (March/April) 2009 pp: 23-30 246.Al-Bader S, Frew SE, Essajee I, Liu VY, Daar AS and Singer PA (2009) "Small but tenacious: South Africa's health biotech sector". Nature Biotechnol 27(5):427-445.(2009) 247.Emerson, Claudia I., Upshur, Ross E. G. and Daar AS (2009) 'Empirical Bioethics Research in the Developing World: When the 'Is' is Close to an 'Ought'', The American Journal of Bioethics,9:6,101 — 103 (2009) 248.Ali-Khan SE, Daar AS, Shuman C, Ray PN, Scherer SW, Whole genome scanning: resolving clinical diagnosis and management amidst complex data. Pediatr Res. 2009 Jun 10. [Epub ahead of print] 249.Emmanuel B Omobowale Singer PA, Daar AS, The three main monotheistic religions and gm food technology: an overview of perspectives; BMC International Health and Human Rights 2009, Published August 22, 2009 250.Ray M, Daar AS, Singer PA, Thorsteinsdóttir H. Globetrotting firms: Canada's health biotechnology collaborations with developing countries. Nature Biotechnology. 27(9): 806-814. (2009) 251.Obidima Ezezika, Fiona Thomas, Jim Lavery, Daar AS, Peter Singer, A Social Audit Model for Agro-biotechnology Initiatives in Developing Countries: Accounting for Ethical, Social, Cultural, and Commercialization Issues, J. Technol. Manag. Innov. 2009, Volume 4, Issue 3, Received August 10, 2009 / Accepted September 21, 2009 252.Jennifer L. Pelley, Abdallah S. Daar, and Marc A. Saner, State of Academic Knowledge on Toxicity and Biological Fate of Quantum Dots, TOXICOLOGICAL SCIENCES 112(2), 276– 296 (2009) doi:10.1093/toxsci/kfp188Advance Access publication August 14, 2009 253.McMahon DS, Thorsteinsdóttir H, Singer PA, Abdallah S. Daar: Cultivating regenerative medicine innovation in China. Regen. Med. 5(1), 35–44(2010) Book Chapters 1. Fabre JW, Daar AS. The expression of normal epithelial membrance antigens on human colorectal and breast carcinomas: Demonstration of hitherto unrecognised heterogeneity within and between tumours. In: Burchiel EW, Rhodes BA, eds. Radioimmunoimaging and Radioimmunotherapy. New York: Elsevier Science Publishing, 1983, pp. 143-57. 2. Daar AS, Lennox ES. Tumour markers and antigens. In: Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publications, 1987, pp.1-26. 3. Daar AS. Monoclonal antibodies: Concepts and applications in cancer research and clinical oncology. In: Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publications, 1987, pp.93-114. 35
  36. 36. Curriculum Vitae, Daar AS 4. Daar AS. Plasma membrane molecular structure, differentiation antigens and the malignant phenotype: Tumour markers in context. In: Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publications, 1987, pp.27-66. 5. Daar AS. Introduction and overview of chapters. In: Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publications, 1987, pp.xv-xx. 6. Dalchau R, Daar AS, Fabre JW. The human Thy-1 analogue. In: Reif AE, Schlesinger M, eds. Thy-1. New York: Marcel Decker, 1987, pp. xxx. 7. Daar AS, Pingle A. Transplantation in the lower Arabian Gulf: Current status and future prospects. In: Hassaballah M, ed. Recent Aspects of the Use of Cyclosporine in Renal Transplantation. Amsterdam: Excerpta Medica, 1987, pp. 12-19. 8. Daar AS. Renal transplantation in developing countries. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice, 3rd edition. Philadelphia: W.B. Saunders, 1988, pp. 709-35. 9. Daar AS. Current practice and the legal, ethical, and religious status of post mortem organ donation in the Islamic World. In: Land W, Dossetor JB, eds. Organ Replacement Therapy: Ethics, Justice and Commerce. Berlin: Springer-Verlag, 1991, pp. 291-299. 10. Daar AS. Rewarded gifting and rampant commercialism in perspective: Is there a difference? In: Land W, Dossetor JB, eds. Organ Replacement Therapy: Ethics, Justice and Commerce. Berlin: Springer-Verlag, 1991, pp. 181-189. 11. Daar AS. Transplantation in developing countries: Economic aspects. In: Ahmed M, Blanchard RJW, Eklof B, Harrison TS, Moazam F, Suleman SK, Talati J, Tibblin S, eds. Surgery for All: A View From the Developing World. Ferozsons: Lahore, 1992. 12. Daar AS. Renal transplantation in developing countries. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice, 4th edition. Philadelphia: W.B. Saunders, 1992; pp. 478-503. 13. Grant CS, Daar AS. Transfusion for Elective Surgery. In: Essien E, ed. Handbook of Blood Transfusion Medicine in Oman. Muscat: Ministry of Health, 1994. 14. Daar AS, Grant CS. Transfusion in surgical emergencies. In: Essien E, ed. Handbook of Blood Transfusion Medicine in Oman. Muscat: Ministry of Health, 1994. 15. Mabogunje OA, Grant CS, Daar AS. Biliary and intestinal trematodes. In: Morris PJ, Malt RA. Oxford Textbook of Surgery. Oxford: Oxford University Press, 1994, pp. 2569-76. 16. Grant CS, Daar AS. Typhoid fever and other salmonella infections. In: Morris PJ, Malt RA. Oxford Textbook of Surgery. Oxford: Oxford University Press, 1994, pp. 2478-9. 17. Mabogunje OA, Daar AS. Ascariasis and other intestinal nematode infections. In: Morris PJ, Malt RA. Oxford Textbook of Surgery. Oxford: Oxford University Press, 1994, pp. 2500-7. 18. Daar AS. Schistosomiasis (bilharziasis). In: Morris PJ, Malt RA. Oxford Textbook of Surgery, Oxford: Oxford University Press, 1994, pp. 2511-23. 36

×